
Biosimilars· May 21, 2026 · 7 min read
Herceptin biosimilars: FDA status, payer coverage, coding, and switching
By Ran Chen#Biosimilars#Oncology#Coverage Access
Healthcare Common Procedure Coding System codes, biosimilar Q-codes, J-codes, buy-and-bill billing, and reimbursement.
